These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1874011)

  • 21. Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis.
    Pollicino T; Zanetti AR; Cacciola I; Petit MA; Smedile A; Campo S; Sagliocca L; Pasquali M; Tanzi E; Longo G; Raimondo G
    Hepatology; 1997 Aug; 26(2):495-9. PubMed ID: 9252165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].
    Woo SY; Cho SH; Lee SM; Koh MB; Noh CH; Kim CW; Choi JY; Yang JM; Han JY; Lee YS
    Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.
    Hsieh YH; Su IJ; Wang HC; Chang WW; Lei HY; Lai MD; Chang WT; Huang W
    Carcinogenesis; 2004 Oct; 25(10):2023-32. PubMed ID: 15180947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrahepatic expression of pre-S proteins of hepatitis B virus and its possible relation to liver cell necrosis.
    Hu KQ; Hao LJ; Zhang YY; Wang YK
    Am J Gastroenterol; 1989 Dec; 84(12):1538-42. PubMed ID: 2596456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The decline of hepatitis B viral infection in South-Western Saudi Arabia.
    Ayoola AE; Tobaigy MS; Gadour MO; Ahmad BS; Hamza MK; Ageel AM
    Saudi Med J; 2003 Sep; 24(9):991-5. PubMed ID: 12973485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anti-idiotypic antibodies against antibodies to HBsAg and against antibodies to pre-S1 and pre-S2 fragments of HBV in patients with chronic HBs antigenemia].
    Jagielski P; Nitkiewicz J; Swiderska H; Kalinowska B
    Med Dosw Mikrobiol; 1996; 48(1-2):79-85. PubMed ID: 8926772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
    Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.
    Murakami Y; Minami M; Daimon Y; Okanoue T
    J Med Virol; 2004 Feb; 72(2):203-14. PubMed ID: 14695661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization.
    Zheng X; Schirmbeck R; Hilken G; Waters JA; Yang D; Reimann J; Roggendorf M; Lu M
    Virology; 2002 Mar; 294(2):342-53. PubMed ID: 12009876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of Pre-S1 and Pre-S2 in serum of patients with chronic type B hepatitis].
    Jia W; Rapicetta M; Taliani A
    Hua Xi Yi Ke Da Xue Xue Bao; 1990 Sep; 21(4):383-6. PubMed ID: 2094634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissociated antibody responses to the S and pre-S2 regions of the hepatitis B virus after vaccination in hemophiliacs.
    Zanetti A; Tanzi E; Mannucci PM
    J Med Virol; 1989 Jul; 28(3):156-8. PubMed ID: 2526861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune response to hepatitis B virus surface antigen peptides during HBV infection.
    Mishra A; Durgapal H; Manivel V; Acharya SK; Rao KV; Panda SK
    Clin Exp Immunol; 1992 Nov; 90(2):194-8. PubMed ID: 1424274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of measurement of pre-S2 antigen for the prevention of vertical transmission of hepatitis B virus in infants born to HBsAg carrier mothers.
    Terazawa S; Kondo N; Orii T
    Acta Paediatr; 1994 Jan; 83(1):30-4. PubMed ID: 8193470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-pre-S2 antibodies in natural hepatitis B virus infection and after immunization.
    Coursaget P; Adamowicz P; Bourdil C; Yvonnet B; Buisson Y; Barrès JL; Saliou P; Chiron JP; Mar ID
    Vaccine; 1988 Aug; 6(4):357-61. PubMed ID: 2973189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two vaccinia virus recombinants expressing HBsAg with different concentration of A- and pre-S2 antigenic determinants.
    Chelyapov NV; Rakhilina LE; Antonova TP; Chernos VI; Grigorjev VG; Chudakova EA; Pashvykina GV; Zakharova LG; Altstein AD; Kutinová L
    Acta Virol; 1991 Sep; 35(5):413-22. PubMed ID: 1726675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.